TMCnet News
AAHRPP Accredits Five More Research Entities21 more organizations earn reaccreditation WASHINGTON, June 30, 2026 /PRNewswire/ -- The Association for the Accreditation of Human Research Protection Programs has awarded full accreditation to five more entities, including the U.S. health professions academy and one of the world's leading pharmaceutical companies. The newly accredited entities are:
They join more than 600 entities worldwide in committing to AAHRPP's robust standards for high-quality, ethical research that prioritizes the protection of research participants. "In today's global research enterprise, each accreditation has enormous potential to enhance the quality of research, strengthen research protections, and help restore public trust in science," AAHRPP President and CEO Elyse I. Summers said. She noted the significance of the decision by the Uniformed Services University—a U.S. government institution—to pursue AAHRPP accreditation, especially during such challenging times. "This accreditation sends a deliberate, powerful message about the organization's dedication to safe, ethical research and AAHRPP's invaluable role in supporting that effort," Summers said. AAHRPP has also awarded reaccreditation to the following:
To earn and maintain accreditation, organizations must demonstrate that they adhere to AAHRPP's high standards for research. These include incorporating extensive safeguards throughout their research operation and committing to a culture of continuous improvement. In a global, collaborative research environment, accreditation status can provide added assurance and a competitive edge. AAHRPP has accredited research entities across the U.S. and in Australia, Belgium, Brazil, Canada, China, India, Japan, Jordan, Mexico, Republic of Korea, Saudi Arabia, Singapore, Taiwan, Thailand, and the United Arab Emirates. To learn more, visit www.aahrpp.org. FOR MORE INFORMATION CONTACT:
SOURCE Association for the Accreditation of Human Research Protection Programs
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
